Consultant & Director
Lixte Biotechnology Holdings, Inc.
(NASDAQ: LIXT)
Gil N. Schwartzberg, JD, ScD (hon) has been a consultant to Lixte since the company’s inception. Prior to which, he was the Chief Executive Officer and Chairman of the Board of Directors of the City of Hope National Medical center, an NCI designated Comprehensive Cancer Center. Mr. Schwartzberg was the only person in the City of Hope’s 100-year history to hold both CEO and Board Chair positions.
He is currently Chairman Emeritus for life. His leadership and perceptive insights into the complexities of integrating basic science research with state-of-the-art compassionate patient care and the accreditation of the Graduate School of Biological Sciences at City of Hope during his tenure as president, were recognized by that institution in 2003 by awarding Mr. Schwartzberg a Doctor of Science degree, the first such degree awarded by the graduate school.
During his extensive career he has held positions of major responsibility in: law, biomedicine, banking, apparel/shoe manufacturing and fast food retailing. He has overseen the process by which over a dozen companies have become publicly traded, on all of the United States securities exchanges.